Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 12, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 213
- −3 vs. Q1 2021
- Portfolio value
- $10.2B
- +$792.7M (+8.4%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRNAModerna, Inc. | Stock | 2,542,300 | $597.4M | 5.8% | −267,650−9.5% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 9,930,245 | $396.1M | 3.9% | +946,011+10.5% | Added | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 1,733,694 | $349.6M | 3.4% | +356,990+25.9% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 3,017,751 | $293.7M | 2.9% | −256,800−7.8% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 974,038 | $293.3M | 2.9% | +19,484+2.0% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 1,549,092 | $262.6M | 2.6% | −78,022−4.8% | Reduced | History |
| INCYIncyte Corp | COM | 2,971,400 | $250.0M | 2.4% | −34,300−1.1% | Reduced | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 4,352,992 | $239.9M | 2.3% | −184,100−4.1% | Reduced | History |
| FATEFate Therapeutics Inc | COM | 2,613,536 | $226.8M | 2.2% | +404,200+18.3% | Added | History |
| MGNXMacrogenics Inc | COM | 7,376,026 | $198.1M | 1.9% | +1,348,100+22.4% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 202,095 | $185.9M | 1.8% | −18,680−8.5% | Reduced | History |
| BIIBBiogen Inc. | COM | 528,100 | $182.9M | 1.8% | −30,300−5.4% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 465,976 | $177.9M | 1.7% | +80,428+20.9% | Added | History |
| ARVNArvinas, Inc. | COM | 2,237,403 | $172.3M | 1.7% | +165,900+8.0% | Added | History |
| ABTAbbott Laboratories | Stock | 1,377,499 | $159.7M | 1.6% | −15,500−1.1% | Reduced | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 966,884 | $156.5M | 1.5% | −11,500−1.2% | Reduced | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 3,609,919 | $147.4M | 1.4% | −50,000−1.4% | Reduced | History |
| Radius Health, Inc.750469207 | COM NEW | 7,531,414 | $137.4M | 1.3% | 00.0% | Unchanged | – |
| UNHUnitedHealth Group Inc | Stock | 343,051 | $137.4M | 1.3% | −14,330−4.0% | Reduced | History |
| SAGESage Therapeutics, Inc. | COM | 2,364,204 | $134.3M | 1.3% | +553,500+30.6% | Added | History |
| DHRDanaher Corp | Stock | 482,940 | $129.6M | 1.3% | +9,800+2.1% | Added | History |
| HUMHumana Inc | Stock | 282,755 | $125.2M | 1.2% | −5,964−2.1% | Reduced | History |
| MYOVMyovant Sciences Ltd. | COM | 5,269,039 | $120.0M | 1.2% | +75,000+1.4% | Added | History |
| BDXBecton Dickinson & Co | Stock | 460,965 | $112.1M | 1.1% | 00.0% | Unchanged | History |
| AXNXAxonics, Inc. | COM | 1,730,471 | $109.7M | 1.1% | +274,197+18.8% | Added | History |
| DXCMDexcom Inc | COM | 244,776 | $104.5M | 1.0% | +28,583+13.2% | Added | History |
| CNCCentene Corp | Stock | 1,386,297 | $101.1M | 1.0% | +95,700+7.4% | Added | History |
| HALOHalozyme Therapeutics, Inc. | COM | 2,224,466 | $101.0M | 1.0% | −787,500−26.1% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 2,326,787 | $99.5M | 1.0% | 00.0% | Unchanged | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 1,020,368 | $99.4M | 1.0% | +493,234+93.6% | Added | History |
| SWAVShockwave Medical, Inc. | COM | 516,915 | $98.1M | 1.0% | +32,351+6.7% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 1,463,432 | $97.8M | 1.0% | −621,720−29.8% | Reduced | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 544,750 | $96.8M | 0.9% | −5,900−1.1% | Reduced | History |
| RLAYRelay Therapeutics, Inc. | COM | 2,640,962 | $96.6M | 0.9% | +709,618+36.7% | Added | History |
| ALGNAlign Technology Inc | COM | 156,770 | $95.8M | 0.9% | +12,810+8.9% | Added | History |
| ESPREsperion Therapeutics, Inc. | COM | 4,519,164 | $95.6M | 0.9% | +530,000+13.3% | Added | History |
| ACCDAccolade, Inc. | COM | 1,724,699 | $93.7M | 0.9% | +163,578+10.5% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 890,256 | $92.2M | 0.9% | 00.0% | Unchanged | History |
| SYKStryker Corp | Stock | 344,514 | $89.5M | 0.9% | 00.0% | Unchanged | History |
| INSMINSMED Inc | COM PAR $.01 | 3,120,901 | $88.8M | 0.9% | +643,735+26.0% | Added | History |
| PODDInsulet Corp | Stock | 322,119 | $88.4M | 0.9% | −112,069−25.8% | Reduced | History |
| BEAMBeam Therapeutics Inc. | COM | 612,821 | $78.9M | 0.8% | +46,000+8.1% | Added | History |
| EVHEvolent Health, Inc. | CL A | 3,638,411 | $76.8M | 0.8% | +109,864+3.1% | Added | History |
| HRCHill-Rom Holdings, Inc. | COM | 673,878 | $76.5M | 0.7% | +13,250+2.0% | Added | History |
| MTEMMolecular Templates, Inc. | COM | 9,628,621 | $75.3M | 0.7% | +1,480,516+18.2% | Added | History |
| IDXXIDEXX Laboratories Inc | COM | 118,120 | $74.6M | 0.7% | +26,871+29.4% | Added | History |
| BAXBaxter International Inc | Stock | 900,623 | $72.5M | 0.7% | +426,000+89.8% | Added | History |
| INSPInspire Medical Systems, Inc. | COM | 373,226 | $72.1M | 0.7% | +53,038+16.6% | Added | History |
| NKTRNektar Therapeutics | COM | 4,101,404 | $70.4M | 0.7% | +146,800+3.7% | Added | History |
| EPIXESSA Pharma Inc. | COM NEW | 2,459,814 | $70.3M | 0.7% | +634,000+34.7% | Added | History |
| HCAHCA Healthcare, Inc. | COM | 334,273 | $69.1M | 0.7% | −40,290−10.8% | Reduced | History |
| GBIOGeneration Bio Co. | COM | 2,478,180 | $66.7M | 0.7% | +85,000+3.6% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 2,297,625 | $66.4M | 0.6% | +166,500+7.8% | Added | History |
| CRLCharles River Laboratories International, Inc. | COM | 178,270 | $65.9M | 0.6% | −10,115−5.4% | Reduced | History |
| SILKSilk Road Medical Inc | COM | 1,293,759 | $61.9M | 0.6% | +134,835+11.6% | Added | History |
| HOLXHologic Inc | COM | 913,752 | $61.0M | 0.6% | 00.0% | Unchanged | History |
| CICigna Group | Stock | 256,742 | $60.9M | 0.6% | −191,420−42.7% | Reduced | History |
| OMCLOmnicell, Inc. | COM | 393,583 | $59.6M | 0.6% | +65,664+20.0% | Added | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 105,660 | $59.0M | 0.6% | +69,860+195.1% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 1,854,805 | $58.9M | 0.6% | +789,035+74.0% | Added | History |
| PACBPacific Biosciences of California, Inc. | COM | 1,643,159 | $57.5M | 0.6% | +25,654+1.6% | Added | History |
| GMEDGlobus Medical Inc | Stock | 729,420 | $56.6M | 0.6% | +81,911+12.7% | Added | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 87,301 | $56.2M | 0.5% | −12,901−12.9% | Reduced | History |
| VEEVVeeva Systems Inc | Stock | 172,647 | $53.7M | 0.5% | +19,847+13.0% | Added | History |
| EXELExelixis, Inc. | COM | 2,932,000 | $53.4M | 0.5% | −12,500−0.4% | Reduced | History |
| MOHMolina Healthcare, Inc. | COM | 198,734 | $50.3M | 0.5% | −6,500−3.2% | Reduced | History |
| PENPenumbra Inc | COM | 182,125 | $49.9M | 0.5% | +2,250+1.3% | Added | History |
| ABMDAbiomed Inc | COM | 151,178 | $47.2M | 0.5% | +8,494+6.0% | Added | History |
| GHGuardant Health, Inc. | COM | 379,609 | $47.1M | 0.5% | +76,743+25.3% | Added | History |
| TXG10x Genomics, Inc. | CL A COM | 232,672 | $45.6M | 0.4% | +3,633+1.6% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 280,082 | $45.0M | 0.4% | 00.0% | Unchanged | History |
| MDTMedtronic plc | Stock | 359,625 | $44.6M | 0.4% | +27,103+8.2% | Added | History |
| IQVIQVIA Holdings Inc. | Stock | 177,400 | $43.0M | 0.4% | +175,600+9,755.6% | Added | History |
| TDOCTeladoc Health, Inc. | COM | 257,948 | $42.9M | 0.4% | +3,371+1.3% | Added | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 3,463,000 | $42.2M | 0.4% | +1,220,000+54.4% | Added | History |
| GKOSGLAUKOS Corp | COM | 495,432 | $42.0M | 0.4% | +6,090+1.2% | Added | History |
| HCATHealth Catalyst, Inc. | COM | 753,621 | $41.8M | 0.4% | +11,766+1.6% | Added | History |
| TFXTeleflex Inc | COM | 100,161 | $40.2M | 0.4% | −21,200−17.5% | Reduced | History |
| MRSNMersana Therapeutics, Inc. | COM | 2,941,000 | $39.9M | 0.4% | +90,990+3.2% | Added | History |
| ADPTAdaptive Biotechnologies Corp | COM | 962,352 | $39.3M | 0.4% | +962,352 | New | History |
| OPCHOption Care Health, Inc. | COM NEW | 1,790,192 | $39.2M | 0.4% | +281,872+18.7% | Added | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 417,700 | $39.1M | 0.4% | +9,200+2.3% | Added | History |
| PHRPhreesia, Inc. | COM | 622,542 | $38.2M | 0.4% | +9,529+1.6% | Added | History |
| QTRXQuanterix Corp | COM | 637,815 | $37.4M | 0.4% | −59,617−8.5% | Reduced | History |
| NEONeogenomics Inc | COM NEW | 818,313 | $37.0M | 0.4% | +30,360+3.9% | Added | History |
| ABBVAbbVie Inc. | Stock | 324,200 | $36.5M | 0.4% | −59,900−15.6% | Reduced | History |
| ILMNIllumina, Inc. | COM | 75,330 | $35.6M | 0.3% | +14,412+23.7% | Added | History |
| EXASExact Sciences Corp | COM | 275,673 | $34.3M | 0.3% | +57,533+26.4% | Added | History |
| HCMHUTCHMED (China) Ltd | SPONSORED ADS | 864,760 | $34.0M | 0.3% | −110,728−11.4% | Reduced | History |
| AMGNAmgen Inc | Stock | 129,580 | $31.6M | 0.3% | −46,860−26.6% | Reduced | History |
| MASIMasimo Corp | COM | 127,713 | $31.0M | 0.3% | +1,517+1.2% | Added | History |
| NVRONevro Corp | COM | 183,201 | $30.4M | 0.3% | +2,188+1.2% | Added | History |
| ATRCAtriCure, Inc. | COM | 374,418 | $29.7M | 0.3% | −123,294−24.8% | Reduced | History |
| COOCooper Companies, Inc. | COM NEW | 74,266 | $29.4M | 0.3% | +4,899+7.1% | Added | History |
| ONCBeOne Medicines Ltd. | ADR | 84,300 | $28.9M | 0.3% | +24,600+41.2% | Added | History |
| ONEM1Life Healthcare Inc | COM | 836,190 | $27.6M | 0.3% | +13,055+1.6% | Added | History |
| AMWLAmerican Well Corp | CL A | 2,141,758 | $26.9M | 0.3% | +273,325+14.6% | Added | History |
| VCRAVocera Communications, Inc. | COM | 652,832 | $26.0M | 0.3% | +160,725+32.7% | Added | History |
| NEUENeueHealth, Inc. | COM | 1,500,000 | $25.7M | 0.3% | +1,500,000 | New | History |
| KZRKezar Life Sciences, Inc. | COM | 4,533,148 | $24.6M | 0.2% | 00.0% | Unchanged | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Curevac N VN2451R105 | COM | – | $39.0K |
Sold out since Q1 2021 (15)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| DVADavita Inc. | COM | 367,600 | $39.6M | 0.4% | History |
| NUANNuance Communications, Inc. | COM | 468,885 | $20.5M | 0.2% | History |
| IRTCiRhythm Holdings, Inc. | COM | 87,631 | $12.2M | 0.1% | History |
| TRHCTabula Rasa HealthCare, Inc. | COM | 227,178 | $10.5M | 0.1% | History |
| Curevac N VN2451R105 | COM | 28,900 | $2.64M | <0.1% | – |
| GW Pharmaceuticals PLC36197T103 | ADS | 10,000 | $2.17M | <0.1% | – |
| KYNBKyntra Bio, Inc. | COM | 60,000 | $2.08M | <0.1% | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 15,500 | $2.00M | <0.1% | History |
| SRPTSarepta Therapeutics, Inc. | COM | 20,300 | $1.51M | <0.1% | History |
| CAHCardinal Health Inc | Stock | 24,000 | $1.46M | <0.1% | History |
| YI111, Inc. | ADS | 85,000 | $1.17M | <0.1% | History |
| QUREuniQure N.V. | SHS | 34,500 | $1.16M | <0.1% | History |
| PAYXPaychex Inc | Stock | 3,900 | $382.0K | <0.1% | History |
| ICPTIntercept Pharmaceuticals, Inc. | COM | 8,000 | $185.0K | <0.1% | History |
| VYGRVoyager Therapeutics, Inc. | COM | 31,800 | $150.0K | <0.1% | History |